The Association of Serum Uric Acid Level With Coronary Collateral Circulation Should Be Interpreted Together With Renal Function and Cardiovascular Medications in Stable Coronary Artery Disease
Restricted accessLetterFirst published online March, 2014
The Association of Serum Uric Acid Level With Coronary Collateral Circulation Should Be Interpreted Together With Renal Function and Cardiovascular Medications in Stable Coronary Artery Disease
UysalOKSahinDYDuranM. Association Between Uric Acid and Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease. Angiology. 2014;65(3):227–231.
2.
DuranMKalayNAkpekM. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology. 2012;63(6):448–452.
3.
DuranMOrnekEMuratSN. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology. 2012;63(6):472–475.
4.
KasapkaraHATopsakalRYarliogluesM. Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis. 2012;23(7):421–425.
5.
KayaEBYorgunHCanpolatU. Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. Atherosclerosis. 2010;213(1):178–183.
6.
NyrnesAToftINjolstadI. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women—the Tromso Study [published online August 30, 2013]. Europace. 2013.
7.
HuangHHuangBLiY. Uric acid and risk of heart failure: a systematic review and meta-analysis [published online August 9, 2013]. Eur J Heart Fail. 2013.
8.
LinSDTsaiDHHsuSR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 2006;69(11):512–516.
9.
YooTWSungKCShinHS. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928–933.
10.
SowersJR. Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome. Am J Cardiol. 2003;91(4A):14B–22B.
11.
AikawaM. Effects of statin therapy on vascular dysfunction. Coron Artery Dis. 2004;15(5):227–233.
12.
Skaletz-RorowskiAWalshK. Statin therapy and angiogenesis. Curr Opin Lipidol. 2003;14(6):599–603.
13.
WalterDHZeiherAMDimmelerS. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coron Artery Dis. 2004;15(5):235–242.
14.
NishikawaHMiuraSZhangB. Pravastatin promotes coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis. 2002;13(7):377–381.
15.
ZbindenSBrunnerNWustmannKBillingerMMeierBSeilerC. Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart. 2004;90(4):448–449.
16.
DincerIOngunATurhanSOzdolCKumbasarDErolC. Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis. 2006;17(6):561–565.
17.
AthyrosVGMikhailidisDPLiberopoulosEN. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant. 2007;22(1):118–127.
18.
OgataNFujimoriSOkaYKanekoK. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleosides Nucleotides Nucleic Acids. 2010;29(4-6):321–324.
19.
KadiHCeyhanKSogutE. Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. Clin Cardiol. 2011;34(10):617–621.
